🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12444+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12444 recruiting trials

Phase 3RecruitingNCT06007690

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

👨‍⚕️ Medical Monitor, Aura Biosciences📍 71 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05996627

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

👨‍⚕️ Stephanie Lee, MD, MPH, Fred Hutch/University of Washington Cancer Consortium📍 4 sites📅 Started Dec 2023View details ↗
NARecruitingNCT06213012

Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury

👨‍⚕️ Dimitry Sayenko, MD, PhD, The Methodist Hospital Research Institute📍 1 site📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT05333523

Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.

🏥 Radboud University Medical Center📍 9 sites📅 Started Dec 2023View details ↗
RecruitingNCT05864976

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

👨‍⚕️ Dimitrios Mathios, M.D., Washington University School of Medicine📍 1 site📅 Started Dec 2023View details ↗
Phase 4RecruitingNCT06317805

Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

🏥 AOP Orphan Pharmaceuticals AG📍 19 sites📅 Started Dec 2023View details ↗
NARecruitingNCT06069830

PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma

🏥 Ruijin Hospital📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT05888688

The Sarcopenia Study

👨‍⚕️ Gerry McCann, BSc, MB, ChB, MRCP, MD, University of Leicester (UoL)📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06475976

Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia

👨‍⚕️ Erik Jensen, MD, MSCE, Children's Hospital of Philadelphia📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06152744

Evaluation of Membrane Lung Function in High-altitude Regions

👨‍⚕️ Rui Wang, Dr., Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China📍 1 site📅 Started Dec 2023View details ↗
Phase 1, PHASE2RecruitingNCT06188520

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

👨‍⚕️ Richard Baird, MD, PhD, Cambridge University Hospitals📍 14 sites📅 Started Dec 2023View details ↗
RecruitingNCT06167174

Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis

👨‍⚕️ Xinping Tian, MD, Peking Union Medical College Hospital📍 1 site📅 Started Dec 2023View details ↗
NARecruitingNCT06216808

A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension

👨‍⚕️ SungHoo Hong, MD, The Catholic University of Korea📍 7 sites📅 Started Dec 2023View details ↗
NARecruitingNCT06140901

Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans

👨‍⚕️ Julie MAZENQ, PhD, APHP Marseille📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT05705219

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

👨‍⚕️ Ahmed El Kaffas, PhD, University of California, San Diego📍 3 sites📅 Started Dec 2023View details ↗
RecruitingNCT05628376

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

🏥 University College, London📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06169163

Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

🏥 Imperial College London📍 13 sites📅 Started Dec 2023View details ↗
RecruitingNCT06190834

Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.

👨‍⚕️ Yu Geng, Beijing Tsinghua Changgeng Hospital📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06463717

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

👨‍⚕️ Haitao Meng, Zhejiang University📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06094881

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

👨‍⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Dec 2023View details ↗
← PreviousPage 353 of 623Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →